Carregant...
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections
INTRODUCTION: Oritavancin is a novel lipoglycopeptide approved for acute bacterial skin and skin structure infections. The pharmacokinetic profile and convenient one-time dosing make oritavancin an enticing option for other serious Gram-positive infections requiring prolonged treatment courses. Unfo...
Guardat en:
| Publicat a: | Infect Dis Ther |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5446369/ https://ncbi.nlm.nih.gov/pubmed/28386776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-017-0156-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|